Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 28, 1998

View Archived Issues

Company Profile: CpG ImmunoPharmaceuticals

Gliadel Wafer approved in Canada and France

Dura and Bristol-Myers Squibb sign exclusive license agreement

Shaman achieves favorable phase III results with diarrhea treatment in AIDS patients

Collaborative work by Janssen and Neurocrine Biosciences related to CRF antagonists

New 5-HT4 and/or H3 receptor ligands designed at Synthelabo

Agents for epilepsy, stroke and brain, spinal cord trauma in development at Novartis

Guilford patents NAALADase inhibitors for glutamate abnormalities, prostate conditions

Revolutionary drugs for Alzheimer's ready for human testing described by Nymox

In vivo safety and efficacy of photodynamic therapy evaluated by Theratechnologies in CML patients

Improvement in ischemia-reperfusion lung injury by treatment with FR-167653

Humanized anti-IL-6 antibody shows good efficacy and safety as rheumatoid arthritis Rx

Combination of PGE1 + rolipram or pentoxifylline shows potential for RA

Aged garlic extract: in vitro and in vivo antiallergic effects

First convincing data for extended therapeutic gene expression by human stem cells

Amgen's rights to NESP affirmed by arbitrator panel

Four-year drug target collaboration signed by PPD and RPR

Isis obtains antisense cancer rights from Genzyme Molecular Oncology

Astra and Schering-Plough sign new marketing agreements for several drugs

Pharmacokinetics of YJA-20379-8 not affected by water deprivation in rats

Hyseq presents gene product with potential application to vaccine development

U.S. patent issued for primate embryonic stem cells; Geron holds license

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026